STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune boosting cocktail shows promise for inoperable liver cancer
Disease control Recruiting nowThis study is for people with advanced liver cancer that cannot be surgically removed. It tests whether giving a special immune cell treatment (made from the patient's own blood) along with a pneumonia vaccine and immunotherapy drugs after high-dose radiation is safe and can help…
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 10:44 UTC
-
Promising combo therapy for incurable bile duct cancer enters human trials
Disease control Recruiting nowThis early-stage trial tests whether combining a targeted liver radiation procedure (Y90 radioembolization) with two immunotherapy drugs (durvalumab and tremelimumab) is safe and shows promise for people with bile duct cancer that cannot be surgically removed. The study enrolls 1…
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:04 UTC